Publication: Efficacy and safety of a novel water-soluble herbal patch for acne vulgaris treatment: A randomized, assessor-blinds controlled, intra-individual split-face comparative study
4
0
Issued Date
2021
Resource Type
Language
eng
File Type
application/pdf
ISSN
13960296
Other identifier(s)
2-s2.0-85102365061
Rights Holder(s)
Scopus
Bibliographic Citation
Dermatologic Therapy. Vol 34, No.3 (2021)
Suggested Citation
Jaturapisanukul K., Udompataikul M., Kanokrungsee S., Rojhirunsakool S., Kamanamool N., Rachpirom M., Puttarak P. Efficacy and safety of a novel water-soluble herbal patch for acne vulgaris treatment: A randomized, assessor-blinds controlled, intra-individual split-face comparative study. Dermatologic Therapy. Vol 34, No.3 (2021). doi:10.1111/dth.14925 Retrieved from: https://hdl.handle.net/20.500.14740/7816
Abstract
Acne vulgaris is a chronic inflammatory skin disease. Antibiotics, particularly clindamycin and erythromycin, are used for the treatment of acne vulgaris. However, emerging antibiotic-resistant strains have been an important problem. This study aims to evaluate the efficiency and safety of a novel water-soluble herbal acne patch (WHAP) compared with the hydrocolloid acne patch (HAP) in mild to moderate inflammatory acne patients. The randomized, assessor-blind controlled, intra-individual split-face study was performed on 49 acne patients. The clinical outcomes were evaluated on day 2, 4, 7, 9, and 11 of treatment. It was shown that the median time to resolution of the inflammatory acne treated with WHAP was shorter than HAP with a statistically significant difference (WHAP was 4 days, whereas HAP was 6 days) (P value <.001). Moreover, WHAP had a more significant decrease in the rate of inflammatory diameter, erythema scores (by clinical and colorimetry), and a more increase in the rate of lightness scores (by colorimetry) than HAP (P value <.05). No adverse effects were reported in both groups. It is safe to use WHAP as an alternative treatment for inflammatory acne. © 2021 Wiley Periodicals LLC.
Subject(s)
Alginic acid
Alpha tocopherol
Ascorbic acid
Centella asiatica extract
Cornus officinalis extract
Emblica officinalis extract
Glycerol
Antiinfective agent
Clindamycin
Water
Acne
Acne vulgaris
Adult
Article
Clinical article
Clinical outcome
Colorimetry
Comedo
Comparative study
Controlled study
Device safety
Erythema
Female
Human
Inflammation
Male
Median survival time
Papule
Patch test
Patient satisfaction
Physical examination
Randomized controlled trial
Young adult
Acne vulgaris
Double blind procedure
Skin
Treatment outcome
Acne Vulgaris
Anti-Bacterial Agents
Clindamycin
Double-Blind Method
Humans
Skin
Treatment Outcome
Water
Alpha tocopherol
Ascorbic acid
Centella asiatica extract
Cornus officinalis extract
Emblica officinalis extract
Glycerol
Antiinfective agent
Clindamycin
Water
Acne
Acne vulgaris
Adult
Article
Clinical article
Clinical outcome
Colorimetry
Comedo
Comparative study
Controlled study
Device safety
Erythema
Female
Human
Inflammation
Male
Median survival time
Papule
Patch test
Patient satisfaction
Physical examination
Randomized controlled trial
Young adult
Acne vulgaris
Double blind procedure
Skin
Treatment outcome
Acne Vulgaris
Anti-Bacterial Agents
Clindamycin
Double-Blind Method
Humans
Skin
Treatment Outcome
Water
